Timing of TAP Blocks in Bariatric Surgery
Single Blind Clinical Trial: Optimizing TAP Block Timing for Bariatric Surgery
McMaster University
100 participants
Nov 21, 2024
INTERVENTIONAL
Conditions
Summary
This clinical trial aims to determine the optimal timing for administering a Transversus Abdominis Plane (TAP) block in bariatric surgery, specifically investigating whether initiating TAP blocks at the beginning of surgery is more beneficial than at the end, which is the current practice. The study targets obese patients undergoing bariatric surgery, with a focus on reducing postoperative pain and opioid use. Key outcomes include recovery duration, pain levels, opioid consumption, and respiratory function. Successful results could establish early TAP block initiation as a standard practice, offering faster recovery, decreased opioid reliance, and reduced healthcare costs.
Eligibility
Inclusion Criteria2
- Patients undergoing primary bariatric surgery at St. Joseph's Healthcare Hamilton surgery including Sleeve Gastrectomy (SG) or Roux-en-Y Gastric Bypass Surgery (RYGB)
- Patients >18 Years of Age
Exclusion Criteria2
- Patients undergoing a revisional bariatric surgery
- Patients with a history of chronic pain or opioid use.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A total of 60ml of 0.25% Bupivacaine with Epinephrine, divided into 4 aliquots, will be administered laparoscopically at two locations per side along the anterior axillary line between the costal margin and the iliac crest. TAP block timing will be disclosed to the operating surgeon to ensure the correct solution is administered at the appropriate time.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06270147